Very-low-strength evidence suggests that combining ezetimibe or fibrate with statins is no more effective than high-dose statin monotherapy for reducing all-cause mortality

Alexander Tenenbaum; Enrique Z. Fisman

doi:10.1136/ebm1052

Very-low-strength evidence suggests that combining ezetimibe or fibrate with statins is no more effective than high-dose statin monotherapy for reducing all-cause mortality

Alexander Tenenbaum^*, Enrique Z. Fisman

^*Corresponding author for this work

Clinical Departments

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	52-53
Number of pages	2
Journal	Evidence-Based Medicine
Volume	15
Issue number	2
DOIs	https://doi.org/10.1136/ebm1052
State	Published - Apr 2010

Access to Document

10.1136/ebm1052

Cite this

@article{9b0e4b90125c49a3903ebb3330384f07,

title = "Very-low-strength evidence suggests that combining ezetimibe or fibrate with statins is no more effective than high-dose statin monotherapy for reducing all-cause mortality",

author = "Alexander Tenenbaum and Fisman, {Enrique Z.}",

year = "2010",

month = apr,

doi = "10.1136/ebm1052",

language = "אנגלית",

volume = "15",

pages = "52--53",

journal = "BMJ Evidence-Based Medicine",

issn = "2515-446X",

publisher = "BMJ Publishing Group",

number = "2",

}

TY - JOUR

T1 - Very-low-strength evidence suggests that combining ezetimibe or fibrate with statins is no more effective than high-dose statin monotherapy for reducing all-cause mortality

AU - Tenenbaum, Alexander

AU - Fisman, Enrique Z.

PY - 2010/4

Y1 - 2010/4

UR - http://www.scopus.com/inward/record.url?scp=77951810649&partnerID=8YFLogxK

U2 - 10.1136/ebm1052

DO - 10.1136/ebm1052

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 20436125

AN - SCOPUS:77951810649

SN - 2515-446X

VL - 15

SP - 52

EP - 53

JO - BMJ Evidence-Based Medicine

JF - BMJ Evidence-Based Medicine

IS - 2

ER -

Very-low-strength evidence suggests that combining ezetimibe or fibrate with statins is no more effective than high-dose statin monotherapy for reducing all-cause mortality

Access to Document

Other files and links

Cite this